Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial
Margaret Ross, Ravi Iyer, M.l. Williams, Mark Boughey, Clare O’callaghan, Richard Hiscock, Justin Dwyer
General Hospital Psychiatry August 12, 2025 DOI: 10.1016/j.genhosppsych.2025.08.001 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Individuals with a life-threatening illness |
| Intervention | Psilocybin-assisted psychotherapy |
| Topics | Anxiety Psilocybin Depression Psychedelic-assisted therapy |
| Keywords | Randomized controlled trial Psychotherapist Depression economics Clinical psychology Hallucinogen |
| Citations | 13 |
| Key findings | Psilocybin-assisted psychotherapy appears safe and may offer durable relief from depression and anxiety in individuals with a life-threatening illness. |
Abstract
Psilocybin-assisted psychotherapy appears safe and may offer durable relief from depression and anxiety in individuals with a life-threatening illness.